Accelerated approval for new sickle cell disease treatment
The U.S. Food and Drug Administration (FDA) recently granted accelerated approval to Global Blood Therapeutics’ voxelotor (Oxbryta), a treatment for…
FDA approvals
New treatment for migraine
The U.S. Food and Drug Administration (FDA) recently approved Allergan’s ubrogepant (Ubrelvy) for treatment of acute migraine with or without…